THE Therapeutic Goods
Administration has approved the
Australian registration of Illumina’s
MiSeqDx system, which is an
instrument offering a variety of
assays and kits enabling clinical
laboratories to “create and deploy
next-generation sequencing-based
molecular diagnostic testing”.
The instrument is now cleared
for clinical use in the US, Canada,
Argentina, Europe, South Korea,
Singapore, Thailand and the
Philippines as well as Australia.The above article was sent to subscribers in Pharmacy Daily's issue from 27 May 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 May 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.